| Luis Emilio Scheker, MD | |
|
417 Sw 117th Ave, Suite 210, Portland, OR 97225-5924 | |
| (503) 216-9400 | |
| Not Available |
| Full Name | Luis Emilio Scheker |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 22 Years |
| Location | 417 Sw 117th Ave, Portland, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740293158 | NPI | - | NPPES |
| 500605898 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MD28733 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Portland Medical Center | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Oregon | 0648183608 | 1328 |
News Archive
Doctors from the University of Edinburgh and local intensive care units have linked to fight an antibiotic-resistant infection which attacks some hospital patients.
If the Republics go ahead with the plan to repeal Obamacare, around 32 million Americans would lose their health cover according to a prediction from the Congressional Budget Office (CBO) yesterday. CBO is a non-partisan office that works to analyse pending bills and legislations.
Researchers from Mount Sinai School of Medicine have discovered a novel function of brain insulin, indicating that impaired brain insulin action may be the cause of the unrestrained lipolysis that initiates and worsens type 2 diabetes in humans. The research is published this month in the journal Cell Metabolism.
Softheon, Inc., a proven leader in health insurance marketplace integration and business operation, announced today that Health Republic Insurance Company has chosen the Marketplace Connector Cloud (MC2) as their software platform that will integrate and transition its comprehensive plan offerings for individuals and SHOP plans, both on and off Exchange, to the Federally Facilitated Marketplace.
Findings presented at Digestive Disease Week 2007 (DDW), from long-term extensions of the ACT trials (Active Ulcerative Colitis 1 & 2) show that subjects with moderately to severely active ulcerative colitis (UC) who had responded to REMICADE (infliximab) in the blinded phase of the trials maintained improvement in their clinical symptoms for up to two years.
› Verified 4 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023488343 PECOS PAC ID: 0648183608 Enrollment ID: O20031106000652 |
News Archive
Doctors from the University of Edinburgh and local intensive care units have linked to fight an antibiotic-resistant infection which attacks some hospital patients.
If the Republics go ahead with the plan to repeal Obamacare, around 32 million Americans would lose their health cover according to a prediction from the Congressional Budget Office (CBO) yesterday. CBO is a non-partisan office that works to analyse pending bills and legislations.
Researchers from Mount Sinai School of Medicine have discovered a novel function of brain insulin, indicating that impaired brain insulin action may be the cause of the unrestrained lipolysis that initiates and worsens type 2 diabetes in humans. The research is published this month in the journal Cell Metabolism.
Softheon, Inc., a proven leader in health insurance marketplace integration and business operation, announced today that Health Republic Insurance Company has chosen the Marketplace Connector Cloud (MC2) as their software platform that will integrate and transition its comprehensive plan offerings for individuals and SHOP plans, both on and off Exchange, to the Federally Facilitated Marketplace.
Findings presented at Digestive Disease Week 2007 (DDW), from long-term extensions of the ACT trials (Active Ulcerative Colitis 1 & 2) show that subjects with moderately to severely active ulcerative colitis (UC) who had responded to REMICADE (infliximab) in the blinded phase of the trials maintained improvement in their clinical symptoms for up to two years.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Luis Emilio Scheker, MD Po Box 3158, Portland, OR 97208-3158 Ph: (503) 215-6494 | Luis Emilio Scheker, MD 417 Sw 117th Ave, Suite 210, Portland, OR 97225-5924 Ph: (503) 216-9400 |
News Archive
Doctors from the University of Edinburgh and local intensive care units have linked to fight an antibiotic-resistant infection which attacks some hospital patients.
If the Republics go ahead with the plan to repeal Obamacare, around 32 million Americans would lose their health cover according to a prediction from the Congressional Budget Office (CBO) yesterday. CBO is a non-partisan office that works to analyse pending bills and legislations.
Researchers from Mount Sinai School of Medicine have discovered a novel function of brain insulin, indicating that impaired brain insulin action may be the cause of the unrestrained lipolysis that initiates and worsens type 2 diabetes in humans. The research is published this month in the journal Cell Metabolism.
Softheon, Inc., a proven leader in health insurance marketplace integration and business operation, announced today that Health Republic Insurance Company has chosen the Marketplace Connector Cloud (MC2) as their software platform that will integrate and transition its comprehensive plan offerings for individuals and SHOP plans, both on and off Exchange, to the Federally Facilitated Marketplace.
Findings presented at Digestive Disease Week 2007 (DDW), from long-term extensions of the ACT trials (Active Ulcerative Colitis 1 & 2) show that subjects with moderately to severely active ulcerative colitis (UC) who had responded to REMICADE (infliximab) in the blinded phase of the trials maintained improvement in their clinical symptoms for up to two years.
› Verified 4 days ago
Dr. Alison Marie Small, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 3303 Sw Bond Ave, Portland, OR 97239 Phone: 503-418-3376 | |
Milie Fang, DO Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3303 S Bond Ave Dept, Portland, OR 97239 Phone: 503-494-1375 | |
Bert G Tavelli, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2525 Nw Lovejoy St Ste 400, Portland, OR 97210 Phone: 503-223-1933 Fax: 503-223-1947 | |
Natasha Fewkes Carter, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4914 Sw 1st Ave, Portland, OR 97239 Phone: 310-701-8274 | |
Dr. Samuel Fritz Bremmer, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-8211 | |
Oluwadamilare Olalekan Ajayi, MD Dermatology Medicare: Medicare Enrolled Practice Location: 3303 S Bond Ave, Portland, OR 97239 Phone: 503-418-3376 Fax: 503-494-6968 | |
Diane Romayne Baker, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 9495 Sw Locust St Ste A&e, Portland, OR 97223 Phone: 503-471-0500 Fax: 503-471-0504 |